Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06517940 · ClinicalTrials.gov registry record
A Prospective, Observational Study in Adults With Retinitis Pigmentosa (RP)
A clinical trial of Retinitis Pigmentosa, sponsored by Sumitomo Pharma America.
- Active
- Registry status
- 12
- Enrollment target
- 1
- Study location
NCT06517940 is a study of Retinitis Pigmentosa that is active but no longer recruiting, run by Sumitomo Pharma America. The registered enrollment target is 12 participants, below the 261-participant average among 37 other Retinitis Pigmentosa trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06517940, a study of Retinitis Pigmentosa, is active but no longer recruiting, sponsored by Sumitomo Pharma America.
- ACTIVE NOT RECRUITING
- Registry status
- 12 participants
- Enrollment target
- 1
- Study location
Study Summary
The natural history in individuals with severe retinitis pigmentosa (RP) is variable and there remains an unmet need to better understand disease progression in this population. The goal of this study is to determine which visual assessments individuals with RP and low visual acuity can reliably perform and to evaluate the annual decline of visual function in severe RP.
Conditions Studied
Study Locations (1)
Massachusetts
- Mass Eye and Ear - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2024-10-03 |
| Est. Completion | 2026-04-24 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06517940
The ClinicalTrials.gov registry entry for NCT06517940 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 261-participant average among 37 other Retinitis Pigmentosa trials with a reported enrollment target (95% lower). The listed sponsor is Sumitomo Pharma America, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Retinitis Pigmentosa appearing as the primary indexed condition, and to 0 interventions.
NCT06517940 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06517940 about?
NCT06517940 is a clinical study titled "A Prospective, Observational Study in Adults With Retinitis Pigmentosa (RP)". The natural history in individuals with severe retinitis pigmentosa (RP) is variable and there remains an unmet need to better understand disease progression in this population. The goal of this study is to determine which visual assessments individuals with RP and low visual acuity can reliably per...
What is the current status of trial NCT06517940?
This trial is currently active not recruiting. The enrollment target is 12 participants. The study started on 2024-10-03. Estimated completion is 2026-04-24.
What conditions does trial NCT06517940 study?
This clinical trial studies the following conditions: Retinitis Pigmentosa.
Who is sponsoring clinical trial NCT06517940?
This trial is sponsored by Sumitomo Pharma America, which has 168 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06517940 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Retinitis Pigmentosa
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Promising ROd-cone DYstrophy Gene therapY
RECRUITING · Phase 1
-
High Resolution Retinal Imaging
RECRUITING
-
Safety of a Single, Intravitreal Injection of 6.0M jCell (Famzeretcel) in Retinitis Pigmentosa (RP)
RECRUITING · Phase 2
-
Observational Study to Assess Endpoint Operational Feasibility & Measurement Properties in Patients with Retinal Degeneration
RECRUITING
-
Retinal Imaging in Patients With Inherited Retinal Degenerations
RECRUITING
-
Cell Collection to Study Eye Diseases
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.